# CRISIL share price today (CRISIL Ltd, NSE: CRISIL)

> CRISIL share price today: ₹4,419.40 at the NSE close on 3 November 2026, down 10.3% in a year. CRISIL (NSE: CRISIL) is worth ₹32,316 crore, trades at a P/E of 36.1 and has closed between ₹3,705.90 and ₹4,802.00 over the past 52 weeks. > CRISIL Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 20% of past readings. CRISIL · Credit Rating Agencies · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/crisil-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from the last 12 quarters
- Price: ₹4,419.40 (−10.3% in a year)
- P/E: 36.1× (lower than 80% of the last 11 years)
- Revenue (Sep 2026): ₹1,095 Cr (+20.2% on a year ago)
- Profit (Sep 2026): ₹205 Cr (+6.2% on a year ago)
- Operating margin: 28.0% (−1.0 points on a year ago)
- ROCE: 33%, FY25
- ROIC: 31.2%, against a 12.0% cost of capital: +19.2 points

Biggest thing to watch: the price has already been rising for 8 weeks, so timing is the risk more than the business. ## What is the CRISIL share price today? CRISIL Ltd's share price was ₹4,419.40 at the close on 3 November 2026. It has been rising for 8 weeks. That is 0.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹3,706 and ₹4,802, and at that close it sat 65% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 18 weeks in a row. Over the last 11 years the share price moved +147% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at CRISIL this quarter? Three changes stood out: profit up on a year earlier for 9 quarters in a row, revenue up on a year earlier for 7 quarters in a row and highest quarterly revenue in 16 quarters. 1. Profit up on a year earlier for 9 quarters in a row In the September 2026 quarter profit was ₹205 crore, +6.2% on a year earlier. 2. Revenue up on a year earlier for 7 quarters in a row In the September 2026 quarter revenue was ₹1,095 crore, +20.2% on a year earlier. 3. Highest quarterly revenue in 16 quarters Revenue of ₹1,095 crore in the September 2026 quarter is the highest of the last 16 quarters. ## What are CRISIL's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), CRISIL reported revenue of ₹1,095 crore, up 20.2% from ₹911 crore a year earlier, and a profit of ₹205 crore, up 6.2% from ₹193 crore. ### CRISIL results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹1,095 crore | ₹911 crore | +20.2% |
| Profit | ₹205 crore | ₹193 crore | +6.2% |
| Earnings per share | ₹27.97 | ₹26.41 | +5.9% |
| Operating margin | 28.0% | 29.0% | −1.0 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the CRISIL share price history? CRISIL closed at ₹4,419.40 on 3 November 2026, down 10.3% from ₹4,929.20 a year earlier (31 October 2025) and up 53.4% over five years. Its highest weekly close since March 2016 was ₹6,108.15 on 3 January 2025. ### CRISIL share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹4,751.10 | −7.0% |
| 1 month ago · 1 Oct 2026 | ₹4,428.60 | −0.2% |
| 6 months ago · 30 Apr 2026 | ₹4,288.70 | +3.0% |
| 1 year ago · 31 Oct 2025 | ₹4,929.20 | −10.3% |
| 3 years ago · 3 Nov 2023 | ₹4,199.50 | +5.2% |
| 5 years ago · 4 Nov 2021 | ₹2,880.65 | +53.4% |
| 10 years ago · 4 Nov 2016 | ₹2,212.50 | +99.7% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹1,792.80 | +146.5% |
| Highest weekly close since March 2016 · 3 Jan 2025 | ₹6,108.15 | −27.6% |
| Lowest weekly close since March 2016 · 9 Aug 2019 | ₹1,144.90 | +286.0% |
| 52-week high (weekly close) · 4 Sep 2026 | ₹4,802.00 | −8.0% |
| 52-week low (weekly close) · 2 Apr 2026 | ₹3,705.90 | +19.3% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (563 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on CRISIL? 3 Nov 2026: CRISIL closed at ₹4,419.40, down 7.0% on the week and down 0.2% on the month. 29 Oct 2026: ex-date for an interim dividend of ₹17 a share. ### Earlier

- Results for July to September 2026: Revenue up 20.2% and profit up 6.2% on a year earlier. - 27 Jul 2026: ex-date for an interim dividend of ₹10 a share. - 23 Apr 2026: ex-date for an interim dividend of ₹9 a share. - 2 Apr 2026: ex-date for a dividend of ₹28 a share, record date 3 Apr 2026. ## What dividend does CRISIL pay? CRISIL paid ₹64 a share in regular dividends in the 12 months to 4 November 2026 (4 payments), a yield of 1.45% at the ₹4,419.40 close on 3 November 2026. The last was an interim dividend of ₹17 a share, ex-date 29 October 2026. ### CRISIL dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 29 Oct 2026 | ₹17 | Interim | same day |
| 27 Jul 2026 | ₹10 | Interim | same day |
| 23 Apr 2026 | ₹9 | Interim | same day |
| 2 Apr 2026 | ₹28 | Dividend | 3 Apr 2026 |
| 27 Oct 2025 | ₹16 | Interim | same day |
| 28 Jul 2025 | ₹9 | Interim | same day |
| 7 May 2025 | ₹8 | Interim | same day |
| 11 Apr 2025 | ₹26 | Dividend | 14 Apr 2025 |
| 30 Oct 2024 | ₹15 | Interim | same day |
| 31 Jul 2024 | ₹8 | Interim | same day |
| 3 May 2024 | ₹7 | Interim | same day |
| 28 Mar 2024 | ₹28 | Dividend | n/a |
| 22 Nov 2023 | ₹11 | Interim | same day |
| 2 Aug 2023 | ₹8 | Interim | same day |
| 4 May 2023 | ₹7 | Interim | same day |
| 31 Mar 2023 | ₹23 | Dividend | n/a |
| 4 Nov 2022 | ₹10 | Interim | 7 Nov 2022 |
| 4 Aug 2022 | ₹8 | Interim | 5 Aug 2022 |
| 6 May 2022 | ₹7 | Interim | 9 May 2022 |
| 30 Mar 2022 | ₹22 | Dividend + Special | n/a |
| 24 Nov 2021 | ₹9 | Interim | 25 Nov 2021 |
| 3 Aug 2021 | ₹8 | Interim | 4 Aug 2021 |
| 5 May 2021 | ₹7 | Interim | 6 May 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. CRISIL Ltd paid out 57% of its profit as dividends in FY25, and it paid a dividend in each of its last 12 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is CRISIL on? CRISIL is on 2 of our India lists: Momentum stocks and Small & mid cap stocks. - [Momentum stocks Market cap cr: 33262.55413364034](https://www.sectoralpha.in/momentum-stocks-india)
- [Small & mid cap stocks Size rank in India: 255](https://www.sectoralpha.in/small-cap-stocks-india)

## Is CRISIL profitable? CRISIL Ltd earned ₹205 Cr of net profit in the Sep 2026 quarter, +6.2% on the same quarter a year earlier. That is the 9th quarter in a row of profit growth. Full-year FY25 profit was ₹766 Cr. Over 10 years profit has grown 10.4% a year on average. That is 18.7% of the quarter's revenue. The same quarter a year earlier earned ₹193 Cr. For the full year, FY25 profit was ₹766 Cr (+12.0% on the year before). Why profit moved: revenue changed +20.2% on a year earlier and the margin moved −1.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +21.3% and revenue +24.1%. Profit and revenue are moving at about the same pace. ## How much revenue does CRISIL make, and is it growing? CRISIL Ltd reported ₹1,095 Cr of revenue in the Sep 2026 quarter, +20.2% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 10 years it has grown 10.2% a year on average. The last full year, FY25, came in at ₹3,649 Cr. The last four reported quarters add to ₹4,310 Cr. FY25 revenue was ₹3,649 Cr, +11.9% on the year before. Recent pace: the last four quarters grew +24.1% on average, against 10.2% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +23.9%, against +14.9% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +19.5%, against +15.6% a year (accelerating). ## How much of every ₹100 of sales does CRISIL keep? CRISIL Ltd's operating margin was 28.0% in the Sep 2026 quarter, 1.0 percentage points lower than the same quarter a year ago. Across 12 years it has been between 26.0% and 31.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.4 percentage points on the year while gross margin changed +0.0 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is CRISIL's profit turning into cash? Over the last 3 years, 109% of CRISIL Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in ₹756 Cr of operating cash against ₹766 Cr of profit. After ₹568 Cr of spending on assets, ₹188 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 109% of profit came in as cash: the cash cycle got 12 days longer between FY20 and FY25, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 3.8× depreciation over three years. The next section checks what that spending is building. ## Where does CRISIL's cash go? CRISIL Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 69 days in FY25, up from 57 days in FY20. It spent ₹1,140 Cr on assets over the last 3 years. At FY25 sales of ₹3,649 Cr, each day of that cycle ties up about ₹10.0 Cr, so roughly ₹690 Cr is tied up in the business at any time. Spending on assets: ₹1,140 Cr over the last 3 years, against ₹303 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹30.0 Cr (FY25): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is CRISIL's P/E ratio, and how does it compare with its own history? CRISIL Ltd's P/E is 36.1×, near the low end of its own history: it has been lower only 20% of the time. Its usual P/E (the middle reading) is 45.5×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +12.0% while the price moved −10.3%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +8.9% a year; about +18.3% a year came from earnings growth and about −9.4 percentage points from the multiple (the market paying less); over 10 years the price moved +7.2% a year; about +11.6% a year came from earnings growth and about −4.4 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the CRISIL business getting better or worse? CRISIL Ltd's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 35.8%. This is based on 12 quarters of 4 measures. Why it matters: steady growth with healthy returns is how a business compounds over time. ## How much does CRISIL earn on its capital? CRISIL Ltd earned a ROCE of 33% in FY25. Its return on capital used (ROIC) is 19.2 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 21.0% net margin and 0.80× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 21.0% net margin × 0.80× asset turnover × 1.51× leverage (assets divided by equity) ≈ 25.4% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 31.2% − 12.0% = +19.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. The 31.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 41.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does CRISIL have too much debt? CRISIL Ltd has total debt of ₹335 Cr against shareholder equity of ₹3,271 Cr as of Sep 2026, so its debt is 0.10× its equity, which is very little. Year by year, that ratio went from 0.08 in FY22 to 0.10 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the CRISIL shareholding pattern? No group of CRISIL Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved −0.1 points over the same period, to 12.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −0.3 points over 8 quarters, to 6.9%; Domestic institutions: −0.1 points over 8 quarters, to 12.6%; Promoters: +0.0 points over 8 quarters, to 66.6%. ## How far is CRISIL from balance-sheet trouble? For CRISIL Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does CRISIL rank in its industry? 62.1 out of 100, rank 3 of 3 in Credit Rating Agencies, with 75% of the evidence available. CRISIL Ltd scores 62.1 out of 100 against the 3 companies it is compared with in Credit Rating Agencies, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 18.9 + 21 + 9.7 + 12.5 = 62.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is CRISIL compared with? CRISIL ranks 3 of 3 Credit Rating Agencies companies on the 4-Factor Sector Score, with 62.1 out of 100. 1. [CARE Ratings Ltd](https://www.sectoralpha.in/stocks/care-ratings-ltd) CARERATING · turning · Sector-leading setup · 97% evidence 82.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.5/35 · Revenue 19% · Profit 26.6% · Operating margin change 2 points · 100% evidence Capital efficiency 23.0/25 · ROCE 26.3% · Operating margin 52% · 100% evidence Valuation 13.0/20 · P/E 25.9× · PEG 1.19 · 85% evidence Relative strength 15.2/20 · Lead over its industry 7.1% · Lead over NIFTY 500 7% · 1 year 3.3% · 100% evidence · 1 of 12 weeks ahead Exact sum: 31.5 + 23 + 13 + 15.2 = 82.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [ICRA Ltd](https://www.sectoralpha.in/stocks/icra-ltd) ICRA · basing · Most evidence points up · 82% evidence 67.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 31.3% · Profit 5.8% · Operating margin change 1 points · 100% evidence Capital efficiency 24.0/25 · ROCE 23% · Operating margin 37% · 100% evidence Valuation 12.3/20 · P/E 20.7× · PEG 1.93 · 85% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -15.9% · 1 year -33.1% · 25% evidence · 0 of 12 weeks ahead Exact sum: 23.7 + 24 + 12.3 + 7.5 = 67.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. CRISIL Ltd this page CRISIL · breaking out · Evidence leans up · 75% evidence 62.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.9/35 · Revenue 23.9% · Profit 19.5% · Operating margin change -1 points · 100% evidence Capital efficiency 21.0/25 · ROCE 32.6% · Operating margin 28% · 100% evidence Valuation 9.7/20 · P/E 36.9× · PEG 1.76 · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 8.4% · 1 year -8.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 18.9 + 21 + 9.7 + 12.5 = 62.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Credit Rating Agencies](https://www.sectoralpha.in/sectors/credit-rating-agencies), all 3 compared on one page. ## Which companies are close to CRISIL in size? CRISIL is the largest of 3 Credit Rating Agencies companies on Sector Alpha by market value (scores of 30 October 2026). It is the largest. Just below it: CARE Ratings and ICRA. ### Credit Rating Agencies companies close in size

1. CRISIL Ltd ₹33,030 crore
2. [CARE Ratings Ltd](https://www.sectoralpha.in/stocks/care-ratings-ltd) ₹4,996 crore
3. [ICRA Ltd](https://www.sectoralpha.in/stocks/icra-ltd) ₹4,151 crore

[All 3 Credit Rating Agencies companies, largest first](https://www.sectoralpha.in/sectors/credit-rating-agencies#all-companies)

### Companies close in size in other industries

1. [Gujarat Gas Ltd](https://www.sectoralpha.in/stocks/gujarat-gas-ltd) ₹33,105 crore · Gas Distribution
2. [Sai Life Sciences Ltd](https://www.sectoralpha.in/stocks/sai-life-sciences-ltd) ₹33,093 crore · Pharma - API & CRAMS
3. CRISIL Ltd ₹33,030 crore
4. [Acutaas Chemicals Ltd](https://www.sectoralpha.in/stocks/acutaas-chemicals-ltd) ₹32,778 crore · Pharma - API & CRAMS
5. [3M India Ltd](https://www.sectoralpha.in/stocks/3m-india-ltd) ₹32,672 crore · Diversified

## What else do people ask about CRISIL? ### What is CRISIL's share price today? CRISIL Ltd's share price is ₹4,419.40, −10.3% over the past year. The whole company is worth ₹32,316 Cr on the market. In the last 52 weeks it traded between ₹3,706 to ₹4,802; today it is 65% of the way up from the low, 0.9% below its 200-day average (as of 3 November 2026). ### What were CRISIL's latest quarterly results? CRISIL Ltd reported revenue of ₹1,095 Cr and net profit of ₹205 Cr for the Sep 2026 quarter. Revenue rose 20.2% and profit rose 6.2% compared with a year earlier. Earnings per share were ₹27.97. The operating margin was 28.0%, 1.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is CRISIL's market cap? CRISIL Ltd's market capitalisation is ₹32,316 Cr at a share price of ₹4,419.40. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is CRISIL performing? CRISIL Ltd's share price has been rising for 8 weeks. In its latest quarter, revenue rose 20.2% and profit rose 6.2% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 18 weeks running (as of 3 November 2026). ### Will CRISIL's share price go up? This page does not forecast CRISIL Ltd's share price. What it shows instead: the share price is ₹4,419.40, and it has been rising for 8 weeks. Its P/E of 36.1× is higher than 20% of its own last 11 years (as of 3 November 2026). ### Who owns CRISIL? Promoters own 66.6% of CRISIL Ltd, foreign institutions 6.9%, domestic institutions 12.6% and the public 13.8% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Does CRISIL have too much debt? No, CRISIL Ltd has little debt: its debt is 0.10× its equity, and its operating profit is 49 times its interest bill. FY25 borrowings were ₹297 Cr against equity of ₹3,033 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is CRISIL in its business cycle? CRISIL Ltd's FY25 operating margin was 30.0%, against a 12-year range of 26.0% to 31.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 28.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the CRISIL story? Biggest thing to watch: the price has already been rising for 8 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is CRISIL a stock worth studying right now? What the numbers show: CRISIL Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 20% of past readings. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india
- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india

This is research, not advice. We’re not SEBI-registered.